WallStSmart

Api Group Corp (APG)vsResMed Inc (RMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Api Group Corp generates 48% more annual revenue ($8.17B vs $5.54B). RMD leads profitability with a 27.4% profit margin vs 4.0%. RMD earns a higher WallStSmart Score of 73/100 (B).

APG

Hold

49

out of 100

Grade: D+

Growth: 8.0Profit: 5.5Value: 4.0Quality: 5.5
Piotroski: 5/9Altman Z: 1.69

RMD

Strong Buy

73

out of 100

Grade: B

Growth: 6.7Profit: 9.5Value: 5.3Quality: 8.3
Piotroski: 6/9Altman Z: 4.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

APGSignificantly Overvalued (-23.3%)

Margin of Safety

-23.3%

Fair Value

$36.50

Current Price

$44.67

$8.17 premium

UndervaluedFair: $36.50Overvalued
RMDOvervalued (-13.5%)

Margin of Safety

-13.5%

Fair Value

$228.75

Current Price

$209.64

$19.11 premium

UndervaluedFair: $228.75Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

APG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

Revenue GrowthGrowth
15.3%8/10

15.3% revenue growth

RMD4 strengths · Avg: 9.5/10
Operating MarginProfitability
35.3%10/10

Strong operational efficiency at 35.3%

Altman Z-ScoreHealth
4.3410/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
25.3%9/10

Every $100 of equity generates 25 in profit

Profit MarginProfitability
27.4%9/10

Keeps 27 of every $100 in revenue as profit

Areas to Watch

APG2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.694/10

Distress zone — elevated risk

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

RMD0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : APG

The strongest argument for APG centers on EPS Growth, Revenue Growth. Revenue growth of 15.3% demonstrates continued momentum.

Bull Case : RMD

The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.4% and operating margin at 35.3%. Revenue growth of 10.8% demonstrates continued momentum.

Bear Case : APG

The primary concerns for APG are Altman Z-Score, Profit Margin. Thin 4.0% margins leave little buffer for downturns.

Bear Case : RMD

No major red flags identified for RMD, but monitor valuation.

Key Dynamics to Monitor

APG profiles as a growth stock while RMD is a mature play — different risk/reward profiles.

APG carries more volatility with a beta of 1.69 — expect wider price swings.

APG is growing revenue faster at 15.3% — sustainability is the question.

RMD generates stronger free cash flow (520M), providing more financial flexibility.

Bottom Line

RMD scores higher overall (73/100 vs 49/100), backed by strong 27.4% margins and 10.8% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Api Group Corp

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

APi Group Corporation provides security, specialty and industrial services primarily in North America. The company is headquartered in New Brighton, Minnesota.

Visit Website →

ResMed Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Visit Website →

Want to dig deeper into these stocks?